Sign in
4

Changes in Ownership

Outlook Therapeutics, Inc. Filed Acc 0001415889-24-024701

Options or other derivatives

  • Director acquired 146,185 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
THURMAN RANDY H Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +56,636 56,636 D
THURMAN RANDY H Director 2024-10-01 Grant or award · Stock Option (Right to Buy) +89,549 89,549 D
Loading xslF345X05/form4-10032024_081001.xml…